AW1T:XETRA:XETRA-UBS(Lux)Fund Solutions - MSCI EMU Value UCITS ETF(EUR)A-acc (EUR)

ETF | Others |

Last Closing

USD 18

Change

+0.09 (+0.50)%

Market Cap

N/A

Volume

5.74K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.38%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.38 (+0.38%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.25 (+1.06%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.15 (+1.17%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.06 (+1.13%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.21 (+0.91%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.04 (+0.28%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.66 (+1.20%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.02 (+0.24%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.27 (+0.22%)

USD 12.26B

ETFs Containing AW1T:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.94% 97% N/A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.94% 97% N/A 91% A-
Trailing 12 Months  
Capital Gain 17.34% 91% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.34% 91% A- 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.82% 61% D- 61% D-
Dividend Return 8.82% 60% D- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.32% 68% D+ 75% C
Risk Adjusted Return 106.03% 92% A 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike